Reprise Biomedical, Inc.

What is a Form D filing?

A Form D is the notice a private company files with the U.S. Securities and Exchange Commission when raising capital through an offering exempt under Regulation D (Rule 506(b), 506(c), or 504). It discloses the offering but is not a solicitation, an endorsement, or a statement of investment merit. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Reprise Biomedical, Inc. is identified as a biotech company by its name. Offering of $10M anchors series-a stage; filed under 506(b) exemption.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Filing history

Reprise Biomedical, Inc. has filed 2 Form D filings totaling $18.0M that FormDFlow has indexed.

• May 21, 2026Reg D 506(b)$8.0M

Source

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.